Stocks to Watch on February 1, 2026: Bajaj Auto, Bank of Baroda, Sun Pharma, SAIL, IDFC First Bank and More

Domestic equity benchmarks are likely to witness heightened volatility in the upcoming session, with attention centred on companies that have declared their December quarter results amid ongoing Budget expectations.

A number of stocks across sectors such as steel, automobiles, banking, pharmaceuticals, power and EPC are expected to remain in focus following their latest earnings announcements.

Investor focus will also be influenced by Budget-related developments today.

Steel Authority of India Ltd (SAIL)

SAIL reported its Q3 financial results with a net profit of ₹374 crore.

The company’s revenue stood at ₹27,371 crore, while EBITDA came in at ₹2,294 crore. EBITDA margin for the quarter was recorded at 8.4%, reflecting the company’s operating performance during the period.

Bajaj Auto Ltd

Bajaj Auto posted a strong Q3 performance. Net profit rose 18.6% year-on-year to ₹2,502 crore.

Revenue increased 18.8% to ₹15,220 crore, while EBITDA grew 22.5% to ₹3,161 crore. EBITDA margin improved to 20.8% from 20.2% in the corresponding quarter last year.

NTPC Ltd

NTPC reported a Q3 net profit of ₹4,987 crore, registering a 5.8% year-on-year growth.

Revenue declined marginally by 1.8% to ₹40,643 crore. EBITDA remained largely flat at ₹11,991 crore, though EBITDA margin improved to 29.5% from 28.9% year-on-year.

Bank of Baroda

Bank of Baroda announced a Q3 net profit of ₹5,054 crore, up 4.5% year-on-year.

Net interest income stood at ₹11,800 crore. Asset quality showed improvement, with gross NPAs declining to 2.04%, while net NPAs remained stable at 0.57% on a quarter-on-quarter basis.

Jindal Steel & Power Ltd

Jindal Steel reported a sharp decline in Q3 profitability. Net profit fell 80% year-on-year to ₹188.5 crore.

Revenue, however, rose 10.9% to ₹13,026 crore. EBITDA declined 25.2% to ₹1,632 crore, with margins contracting to 12.5% from 18.6% in the year-ago period.

Glenmark Pharmaceuticals Ltd

Glenmark Pharma delivered a strong Q3 performance. Net profit increased 15.9% year-on-year to ₹403 crore.

Revenue rose 15.1% to ₹3,900 crore, while EBITDA surged 45% to ₹868.7 crore. EBITDA margin expanded significantly to 22.3% from 17.7% a year ago.

KEC International Ltd

KEC International reported a marginal 1.6% year-on-year decline in Q3 net profit to ₹127.5 crore.

Revenue grew 12.2% to ₹6,001 crore, while EBITDA increased 15% to ₹430.3 crore. EBITDA margin edged up to 7.1% from 7% in the previous year.

MedPlus Health Services Ltd

MedPlus Health posted healthy Q3 numbers. Net profit rose 26.2% year-on-year to ₹57.8 crore.

Revenue increased 15.7% to ₹1,806 crore, while EBITDA grew 19.7% to ₹158.5 crore. EBITDA margin improved to 8.78% from 8.48%.

Read More: Key Trends to Watch in Feb 2026: Union Budget 2026, RBI MPC, Auto Sales, and More.

Conclusion

With Q3 earnings announcements continuing and Budget-related developments in focus, investor attention is expected to remain on stocks across steel, automobiles, power, banking, pharmaceuticals and infrastructure sectors. Earnings growth, margin trends and balance sheet strength are likely to drive stock-specific movements in the near term.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.